関連する実験動画
Updated: Mar 24, 2026
06:32
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
3.3K
腫瘍 免疫 学 の 基礎
A Karolina Palucka1, Lisa M Coussens2
1The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT 06032, USA; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Cell
|March 12, 2016
まとめ
免疫系,特にT細胞を活用することで 癌の異質性や治療抵抗性を克服できます 将来の研究は,腫瘍の微小環境内の炎症とT細胞活動をターゲットにすることで,がん治療を改善することを目指しています.
科学分野:
- 免疫学
- 腫瘍学
- 癌 研究
背景:
- 癌の異質性は クローン生存と治療に対する抵抗を促します
- 免疫反応,特に抗原特異性T細胞は,がんを制御する上で重要な役割を果たします.
- T細胞移植やチェックポイントブロックなどの 現在の免疫療法では 免疫系を調節する可能性があることが示されています
研究 の 目的:
- 細胞毒性がん治療の有効性を高めるために 宿主免疫系を より良く活用する方法を探る
- 癌治療の成果を改善するために必要な研究領域を特定する.
- 現在のがん治療に対する耐性を克服するための戦略を開発する.
主な方法:
- 腫瘍を助長する炎症を中和する方法を研究している.
- ワクチンを含め,T細胞のレパートリーを拡大するための戦略を模索する.
- 腫瘍の微小環境内の免疫細胞の組織化メカニズムを明らかにし,T細胞の活動を調節する.
主要な成果:
- 活性免疫反応,特にT細胞は,がんの異質性を形成し,治療に対する耐性を影響する.
- 免疫療法では,T細胞ががんをコントロールする可能性を強調しています.
- 免疫細胞の相互作用を理解することは 腫瘍の微小環境を調節する鍵です
結論:
- 免疫系を活用することで 細胞毒性療法を強化し 患者の治療結果を改善できます
- 腫瘍を誘発する炎症に対処し,T細胞の多様性を拡大し,免疫調節を理解することは重要な研究分野です.
- これらの取り組みは,治療抵抗性に対抗し,長期的ながん制御を達成するための新しい組み合わせの治療法につながるでしょう.
関連する概念動画
01:27Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
01:19Psychoneuroimmunology: Diabetes and Cancer
613
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
613
01:27Cytotoxic T Cells-mediated Immune Response
7.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.9K
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
02:53Adaptive Mechanisms in Cancer Cells
4.2K
4.2K
02:17The Tumor Microenvironment
8.1K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K